Nanomedicines are extensively explored for cancer therapy. By delivering drug molecules
more efficiently to pathological sites and by attenuating their accumulation in healthy organs …

The rapid development of nanomedicines is revolutionizing the landscape of cancer
treatment, while effectively delivering them into solid tumors remains a formidable challenge …

Imidazoquinolines (IMDs), such as resiquimod (R848), are of great interest as potential
cancer immunotherapies because of their ability to activate Toll-like receptor 7 (TLR7) …

Conspectus A host–guest drug delivery system (HGDDS) refers to a host–guest complex of
an artificial receptor and a therapeutic agent which can dissociate at the lesion site and …

Fast-charging Li metal batteries (LMBs) with low cost, high safety, and long lifespan are
highly desirable for next-generation energy storage technologies yet have been rarely …

Immunotherapy has revolutionized the cancer treatment paradigm, yet efficient
immunotherapeutic responses against immune-cold/desert cancers remain challenging …

While Si-containing polymers can often be deconstructed using chemical triggers such as
fluoride, acids, and bases, they are resistant to cleavage by mild reagents such as biological …

Bottlebrush polymers (BBPs) of different architecture are of considerable interest for a broad
range of applications, including nanomedicine, electronics, and self-healing materials …

Injectable biomaterials have been engineered to operate within the human body, offering
versatile solutions for minimally invasive therapies and meeting several stringent …

Ototoxic drugs such as aminoglycoside antibiotics and cisplatin (CDDP) can cause
sensorineural hearing loss (SNHL), which is closely related to oxidative stress and the …